Bell Blake R exercised options and sold 18,000 EXPD shares
Rhea-AI Filing Summary
Bell Blake R, an officer of Expeditors International of Washington, Inc. (EXPD), exercised stock options and sold shares on 08/06/2025. The reporting person exercised 18,000 stock options with an exercise/conversion price of $47.39, then sold 18,000 common shares at a weighted average price of $117.894 (sales ranged from $117.85 to $118.03). After these transactions, the reporting person beneficially owned 57,275.4324 shares directly; immediately after the exercise but before the sale the beneficial ownership was 75,275.4324 shares.
The filing notes 197.6597 shares purchased under the company ESPP on July 31, 2025 are included in the beneficial ownership totals. The derivative table shows zero outstanding stock options for the reporting person following the reported exercise.
Positive
- None.
Negative
- None.
Insights
TL;DR: Officer exercised 18,000 options at $47.39 and sold 18,000 shares at ~$117.89 on 08/06/2025; net direct holdings fell to 57,275.4324 shares.
The transaction pattern—exercise of options followed by an immediate sale of the same number of shares—is a common liquidity event for option holders and often reflects routine monetization of vested compensation. The weighted average sale price is disclosed as $117.894, with the filer offering to provide per-trade amounts on request. The filing also clarifies that 197.6597 ESPP shares purchased on July 31, 2025 are included in the beneficial ownership total. From a monitoring perspective, this is a transparent, fully disclosed Section 16 filing showing conversion of derivatives into common stock and subsequent disposition.
TL;DR: Disclosure shows an exercised-and-sold sequence by an officer; properly reported and signed by an attorney-in-fact.
The Form 4 provides the necessary details required for insider trading transparency: transaction date, option exercise price ($47.39), number of shares exercised and sold (18,000), and the weighted average sale price ($117.894) with a disclosed price range. Beneficial ownership before and after the transactions is reported, and the derivative schedule shows zero remaining options post-exercise. Procedurally, the form appears complete and includes an explanation for the weighted average sale price and ESPP share inclusion, supporting proper governance disclosure practices.